Aktive Positionen von Lisa Goldey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MYOKARDIA, INC. | Corporate Officer/Principal | 17.11.2020 | - |
Karriereverlauf von Lisa Goldey
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Lisa Goldey
- Erfahrung